A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation:effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

Autor: María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Martín Ruiz-Ortiz, Javier Muñiz, Inmaculada Roldán-Rabadán, Déborah Otero, Raquel López-Gálvez, Ángel Cequier, Vicente Bertomeu-Martínez, Lina Badimón, Manuel Anguita, Gregory Y.H. Lip, Francisco Marín

Publikováno v: Esteve-Pastor, M A, Rivera-Caravaca, J M, Ruiz-Ortiz, M, Muñiz, J, Roldán-Rabadán, I, Otero, D, López-Gálvez, R, Cequier, Á, Bertomeu-Martínez, V, Badimón, L, Anguita, M, Lip, G Y H, Marín, F & FANTASIIA Investigators 2022, ' A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation : effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry ', Expert Opinion on Pharmacotherapy, vol. 23, no. 12, pp. 1457-1465 . https://doi.org/10.1080/14656566.2022.2109961
EXPERT OPINION ON PHARMACOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

INTRODUCTION: For a long time, vitamin K antagonists (VKA) were the only oral anticoagulation therapy available to reduce adverse events in atrial fibrillation (AF) patients. Direct-acting oral anticoagulants (DOAC) are at least as effective and safe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99941a30dd09a692d597242ea3d06f68
https://vbn.aau.dk/da/publications/8d9f9409-7ffd-4bb8-a057-f3dd8b9ee797

Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: Real-world data from the FANTASIIA registry

Autor: Javier Muñiz, Inmaculada Roldán-Rabadán, Martín Ruiz Ortiz, Francisco Marín, Amaya García-Fernández, Manuel Anguita, Gregory Y.H. Lip, Vicente Bertomeu-Martínez, Lina Badimon, María Asunción Esteve-Pastor, Angel Cequier, Déborah Otero, Fantasiia Study Investigators

Publikováno v: Annals of medicine
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)
García-Fernández, A, Esteve-Pastor, M A, Roldán-Rabadán, I, Muñiz, J, Ruiz Ortiz, M, Cequier, Á, Bertomeu-Martínez, V, Badimón, L, Otero, D, Anguita, M, Lip, G Y H, Marín, F & on behalf of FANTASIIA investigators 2020, ' Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes : real-world data from the FANTASIIA Registry ', Annals of Medicine, vol. 52, no. 6, pp. 300-309 . https://doi.org/10.1080/07853890.2020.1778176
Ann Med
RUC. Repositorio da Universidade da Coruña
instname

BACKGROUND:Atrial fibrillation (AF) patients with diabetes (DM) are at increased risk of cardiovascular events and have higher related morbidity and mortality. PURPOSE:To compare clinical characteristics, cardiovascular adverse outcomes and quality o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edd9a98bcb56341b96e315709ed6a43a

Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry

Autor: José María Arizón del Prado, Juan Delgado-Jiménez, José Manuel Sobrino Márquez, Félix Pérez-Villa, Gregorio Rábago-Aracil, José González-Costello, Luis Almenar-Bonet, Manuel Martínez-Sellés, Raquel López-Vilella, María G. Crespo-Leiro, Luis de la Fuente-Galán, José Luis Lambert-Rodríguez, María Teresa Blasco-Peiró, Déborah Otero, Iris P. Garrido-Bravo, Manuel Cobo, Sonia Mirabet-Pérez, Francisco González-Vílchez, Javier Segovia-Cubero

Publikováno v: Revista espanola de cardiologia (English ed.)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
REVISTA ESPANOLA DE CARDIOLOGIA
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
RUC. Repositorio da Universidade da Coruña
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)

[Abstract] Introduction and objectives. The age of heart transplant recipients and donors is progressively increasing. It is likely that not all donor-recipient age combinations have the same impact on mortality. The objective of this work was to com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a2616079e0f4ee7cd91a558b3773e78
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13278